Incidence of relapses in patients with purified high dose biotin-treated progressive multiple sclerosis (IPBio-SeP study): a second intermediate analysis of a French, multicenter study

Mathais, S; Moisset, X; Pereira, B; Taithe, F; Ciron, J; Labauge, P; Brochet, B; Laplaud, D; De Seze, J; Pelletier, J; Berger, E; Lebrun-Frenay, C; Castelnovo, G; Edan, G; Defer, G; Bourre, B; Vermersch, P; Camdessanche, JP; Magy, L; Guennoc, AM; Deb

MULTIPLE SCLEROSIS JOURNAL, 2019; 25 (): 335